TULANE ARPA-H INITIATIVE
Information for Tulane Researchers
The Advanced Research Projects Agency for Health (ARPA-H) is a new quasi-independent congressionally directed program to support transformative high-risk, high-reward research to drive biomedical and health breakthroughs. Modeled on DARPA, the new agency is intended to speed the development of treatment and cures for diseases.
ARPA-H is currently funded at $2.5 billion through FY 2025 and employs a DARPA-like proposal, review, and award model that will be guided by program managers and which is exempt from the peer review process. Funded projects will be expected to address difficult health-related challenges that cannot readily be accomplished through traditional research or commercial activity. The program will use a wide range of funding mechanisms to establish multiple programs in the $50-$150 million range and funded projects are expected to rapidly deliver results on-time and on-budget.
Tulane's ARPA-H Task Force, working with the Office of Research, will coordinate development and submission of Tulane's abstracts in response to the initial ARPA-H Broad Agency Announcement. ARPA-H Program Managers will review abstracts internally and then request full proposals from selected abstracts.
Tulane Support for ARPA-H Researchers
Our first ARPA-H Workshop was held on August 30, 2023.
Click the button link below for the slide presentation.
Check back frequently for updates.
Health Science Futures - Expanding what's technically possible
Proactive Health - Keeping people from becoming patients
Scalable Solutions - Reaching everyone quickly
Resilient Systems - Building integrated healthcare systems
1. What are you trying to do? What health problem are you trying to solve?
2. How is it done today? What are the limitations of present approaches?
3. What is new about your approach? Why do you think you can be successful this time?
4. Who cares? If you are succeed, what difference will it make?
5. What are the risks?
6. How long will the program take?
7. How much will it cost?
8. What are the mid-term and final “exams” to check for success?
9. To ensure equitable access to all people, how will cost, accessibility, and user experience be addressed?
10. How might this program be misperceived or misused (and how can you prevent that from happening)?